These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19783900)

  • 1. The biology of hormone refractory breast and prostate cancer: An NCI workshop report.
    Mohla S; Stearns V; Sathyamoorthy N; Rosenfeld MG; Nelson P
    Cancer Biol Ther; 2009 Nov; 8(21):1975-85. PubMed ID: 19783900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
    Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
    Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor involvement in the progression of prostate cancer.
    Suzuki H; Ueda T; Ichikawa T; Ito H
    Endocr Relat Cancer; 2003 Jun; 10(2):209-16. PubMed ID: 12790784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.
    Jordan VC; Fan P; Abderrahman B; Maximov PY; Hawsawi YM; Bhattacharya P; Pokharel N
    Discov Med; 2016 May; 21(117):411-27. PubMed ID: 27355337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the androgen receptor in prostate and breast cancer: several new agents in development.
    Proverbs-Singh T; Feldman JL; Morris MJ; Autio KA; Traina TA
    Endocr Relat Cancer; 2015 Jun; 22(3):R87-R106. PubMed ID: 25722318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
    Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
    Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.
    Takuwa H; Tsuji W; Shintaku M; Yotsumoto F
    BMC Cancer; 2018 Dec; 18(1):1282. PubMed ID: 30577860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging of steroid receptor expression in breast and prostate cancer.
    Hospers GA; Helmond FA; de Vries EG; Dierckx RA; de Vries EF
    Curr Pharm Des; 2008; 14(28):3020-32. PubMed ID: 18991716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers.
    Das K; Lorena PD; Ng LK; Shen L; Lim D; Siow WY; Narasimhan K; Teh M; Choolani M; Putti TC; Salto-Tellez M
    Pathology; 2010; 42(6):540-6. PubMed ID: 20854072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic strategy for targeting therapy in castration-resistant prostate cancer.
    Mendiratta P; Mostaghel E; Guinney J; Tewari AK; Porrello A; Barry WT; Nelson PS; Febbo PG
    J Clin Oncol; 2009 Apr; 27(12):2022-9. PubMed ID: 19289629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abiraterone acetate for the treatment of prostate cancer.
    Ryan CJ; Cheng ML
    Expert Opin Pharmacother; 2013 Jan; 14(1):91-6. PubMed ID: 23199349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid receptors and their role in the biology and control of breast cancer growth.
    Cordera F; Jordan VC
    Semin Oncol; 2006 Dec; 33(6):631-41. PubMed ID: 17145341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone-refractory prostate cancer? Anti-androgen withdrawal and intermittent hormone therapy.
    Sciarra A; Casale P; Colella D; Di Chiro C; Di Silverio F
    Scand J Urol Nephrol; 1999 Aug; 33(4):211-6. PubMed ID: 10515081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer.
    Chen R; Yu Y; Dong X
    J Steroid Biochem Mol Biol; 2017 Feb; 166():91-96. PubMed ID: 27125450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine therapy of breast and prostate cancer.
    Manni A
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.